PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $951,000 | -13.8% | 30,995 | +12.6% | 0.00% | – |
| Q2 2023 | $1,103,000 | +116.3% | 27,536 | +119.9% | 0.00% | – |
| Q1 2023 | $510,000 | -7.1% | 12,523 | -11.9% | 0.00% | – |
| Q4 2022 | $549,000 | +38.6% | 14,217 | +91.2% | 0.00% | – |
| Q3 2022 | $396,000 | -80.5% | 7,436 | -78.6% | 0.00% | -100.0% |
| Q2 2022 | $2,030,000 | -23.5% | 34,798 | +0.1% | 0.00% | 0.0% |
| Q1 2022 | $2,653,000 | +107.8% | 34,748 | +63.9% | 0.00% | – |
| Q4 2021 | $1,277,000 | +28.2% | 21,206 | +19.3% | 0.00% | – |
| Q3 2021 | $996,000 | +12.4% | 17,770 | +21.6% | 0.00% | – |
| Q2 2021 | $886,000 | +21.9% | 14,617 | +41.1% | 0.00% | – |
| Q1 2021 | $727,000 | -45.8% | 10,362 | -53.8% | 0.00% | – |
| Q4 2020 | $1,341,000 | +214.8% | 22,407 | +216.2% | 0.00% | – |
| Q3 2020 | $426,000 | -63.8% | 7,087 | -68.4% | 0.00% | – |
| Q2 2020 | $1,178,000 | +60.1% | 22,456 | +2.4% | 0.00% | – |
| Q1 2020 | $736,000 | +28.9% | 21,932 | +73.7% | 0.00% | – |
| Q4 2019 | $571,000 | +3.6% | 12,625 | -12.8% | 0.00% | – |
| Q3 2019 | $551,000 | -56.2% | 14,482 | -49.9% | 0.00% | -100.0% |
| Q2 2019 | $1,257,000 | +91.9% | 28,888 | +67.9% | 0.00% | – |
| Q1 2019 | $655,000 | -56.8% | 17,206 | -51.2% | 0.00% | -100.0% |
| Q4 2018 | $1,516,000 | +81.1% | 35,259 | +106.9% | 0.00% | – |
| Q3 2018 | $837,000 | +38.3% | 17,043 | -9.6% | 0.00% | – |
| Q2 2018 | $605,000 | -26.7% | 18,845 | -28.8% | 0.00% | – |
| Q1 2018 | $825,000 | +31.8% | 26,472 | +93.3% | 0.00% | – |
| Q4 2017 | $626,000 | -95.9% | 13,696 | -96.6% | 0.00% | -100.0% |
| Q3 2017 | $15,323,000 | -5.8% | 408,095 | +19.7% | 0.01% | -12.5% |
| Q2 2017 | $16,265,000 | +25.7% | 340,971 | +20.1% | 0.01% | +14.3% |
| Q1 2017 | $12,944,000 | +19.9% | 283,822 | -15.1% | 0.01% | +16.7% |
| Q4 2016 | $10,796,000 | -15.2% | 334,227 | -10.2% | 0.01% | -14.3% |
| Q3 2016 | $12,732,000 | +149.7% | 372,052 | +146.2% | 0.01% | +133.3% |
| Q2 2016 | $5,098,000 | +100.8% | 151,111 | +215.3% | 0.00% | +50.0% |
| Q1 2016 | $2,539,000 | +1527.6% | 47,933 | +2255.4% | 0.00% | – |
| Q4 2015 | $156,000 | -11.9% | 2,035 | -52.7% | 0.00% | – |
| Q3 2015 | $177,000 | +52.6% | 4,301 | +162.3% | 0.00% | – |
| Q2 2015 | $116,000 | +54.7% | 1,640 | +94.8% | 0.00% | – |
| Q1 2015 | $75,000 | +38.9% | 842 | +37.1% | 0.00% | – |
| Q4 2014 | $54,000 | -15.6% | 614 | -7.8% | 0.00% | – |
| Q3 2014 | $64,000 | +100.0% | 666 | +90.3% | 0.00% | – |
| Q2 2014 | $32,000 | -80.4% | 350 | -85.0% | 0.00% | – |
| Q1 2014 | $163,000 | +858.8% | 2,333 | +677.7% | 0.00% | – |
| Q4 2013 | $17,000 | +70.0% | 300 | +50.0% | 0.00% | – |
| Q3 2013 | $10,000 | +66.7% | 200 | 0.0% | 0.00% | – |
| Q2 2013 | $6,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |